Weilin Yang

841 total citations
31 papers, 672 citations indexed

About

Weilin Yang is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Weilin Yang has authored 31 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Weilin Yang's work include Glioma Diagnosis and Treatment (3 papers), Cancer Cells and Metastasis (3 papers) and Myasthenia Gravis and Thymoma (3 papers). Weilin Yang is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Cancer Cells and Metastasis (3 papers) and Myasthenia Gravis and Thymoma (3 papers). Weilin Yang collaborates with scholars based in China, United States and Singapore. Weilin Yang's co-authors include Yingna Li, Fajun Chen, Weixia Chen, Shijie Zhang, Han Li, Ke Jian Liu, Rong Pan, Zhifeng Qi, Wenlan Liu and Chunlian Liang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Weilin Yang

30 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weilin Yang China 15 249 139 117 93 87 31 672
Yanchao Jiang United States 16 281 1.1× 83 0.6× 94 0.8× 29 0.3× 40 0.5× 36 760
Fanping Meng China 16 258 1.0× 146 1.1× 46 0.4× 82 0.9× 30 0.3× 38 748
Hiroki Takahashi Japan 20 486 2.0× 128 0.9× 153 1.3× 61 0.7× 29 0.3× 62 1.4k
Naifeng Liu China 18 377 1.5× 157 1.1× 113 1.0× 41 0.4× 25 0.3× 51 878
Hui Wu China 16 279 1.1× 52 0.4× 102 0.9× 85 0.9× 21 0.2× 40 667
Ziwen Lu China 15 358 1.4× 182 1.3× 62 0.5× 73 0.8× 28 0.3× 50 661
Yu Peng China 19 519 2.1× 242 1.7× 102 0.9× 119 1.3× 26 0.3× 50 962
Ke‐Qiong Deng China 16 372 1.5× 112 0.8× 38 0.3× 71 0.8× 25 0.3× 32 787

Countries citing papers authored by Weilin Yang

Since Specialization
Citations

This map shows the geographic impact of Weilin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilin Yang more than expected).

Fields of papers citing papers by Weilin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weilin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilin Yang. The network helps show where Weilin Yang may publish in the future.

Co-authorship network of co-authors of Weilin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Weilin Yang. A scholar is included among the top collaborators of Weilin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weilin Yang. Weilin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Weilin, et al.. (2025). Apoptotic-body-inspired nanoplatform targeting the lung-macrophage-mitochondrial axis for acute lung injury therapy. Journal of Controlled Release. 389. 114413–114413.
2.
Li, Na, Hong‐Yi Zheng, Xiaoyan He, et al.. (2024). Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy. AIDS. 38(6). 803–812. 9 indexed citations
3.
Chang, Chien-Hung, et al.. (2022). Safety and efficacy of drug coated balloon angioplasty for intracranial atherosclerotic disease. Journal of NeuroInterventional Surgery. 15(e2). e172–e177. 9 indexed citations
4.
Cai, Shengwei, et al.. (2022). Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China. World Journal of Clinical Cases. 10(31). 11411–11418. 1 indexed citations
5.
6.
Yang, Weilin, Sai Chen, Xinxin Cheng, et al.. (2021). Characteristics of genomic mutations and signaling pathway alterations in thymic epithelial tumors. Annals of Translational Medicine. 9(22). 1659–1659. 11 indexed citations
7.
Li, Guoming, Hao Lin, Rongfei Wang, et al.. (2021). Application of drug-coated balloons for intracranial atherosclerosis disease: a systematic review. Clinical Neurology and Neurosurgery. 213. 107065–107065. 12 indexed citations
8.
Cheng, Xinxin, Sai Chen, Weilin Yang, et al.. (2021). Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection. Annals of Surgical Oncology. 29(1). 598–605. 2 indexed citations
9.
Li, Jing, Fei Liu, Weilin Yang, et al.. (2020). A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Cancer Imaging. 20(1). 82–82. 41 indexed citations
10.
Zeng, Huilan, Weilin Yang, Bo Xu, et al.. (2020). Relationship of possible biomarkers with malignancy of thymic tumors: a meta-analysis. BMC Cancer. 20(1). 928–928. 3 indexed citations
12.
Yang, Weilin, Bo Xu, Jianyong Zou, et al.. (2018). Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. BMC Cancer. 18(1). 976–976. 41 indexed citations
13.
Lei, Yiyan, Zhaoguo Liu, & Weilin Yang. (2018). Negative correlation of cytoplasm TIMP3 with miR-222 indicates a good prognosis for NSCLC. OncoTargets and Therapy. Volume 11. 5551–5557. 17 indexed citations
14.
Wang, Junjie, Weilin Yang, Tao Wang, et al.. (2018). Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial–Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells. Scientific Reports. 8(1). 5422–5422. 16 indexed citations
15.
Yang, Weilin, et al.. (2016). Lp-PLA2 silencing protects against ox-LDL-induced oxidative stress and cell apoptosis via Akt/mTOR signaling pathway in human THP1 macrophages. Biochemical and Biophysical Research Communications. 477(4). 1017–1023. 26 indexed citations
16.
Chen, Zhenguang, et al.. (2015). Specific Safety Profile of Bevacizumab in Asian Patients With Advanced NSCLC. Medicine. 94(24). e975–e975. 13 indexed citations
17.
Liang, Chunlian, et al.. (2015). The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis. Experimental and Molecular Pathology. 99(2). 279–285. 33 indexed citations
18.
Zhong, Beilong, Tao Wang, Jinli Zhang, et al.. (2014). Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis. Cancer Cell International. 14(1). 57–57. 18 indexed citations
19.
Zhang, Lin, Yingna Li, Chunlian Liang, & Weilin Yang. (2013). CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. International Journal of Molecular Medicine. 33(2). 478–486. 35 indexed citations
20.
Li, Yingna, Miaomiao Xi, Yu Guo, et al.. (2013). NADPH oxidase-mitochondria axis-derived ROS mediate arsenite-induced HIF-1α stabilization by inhibiting prolyl hydroxylases activity. Toxicology Letters. 224(2). 165–174. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026